Advances in Multiple Sclerosis Research-Series I

Advances in Multiple Sclerosis Research-Series I

Designing immunotherapeutics, drugs, and anti-inflammatory reagents has been at the forefront of autoimmune research, in particular multiple sclerosis, for over 20 years. Delivery methods that are used to modulate effective and long-lasting immune responses have been the major focus. This Special Is...

Full description

Bibliographic Details
Format:	eBook
Language:	English
Published:	Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021
Subjects:	Medicine adult-onset agonist peptide alemtuzumab altered peptide ligands antibodies against GluR3 peptide antibody detection antigen-specific immunotherapies antigen-specific immunotherapy astrocytes autoimmune diseases autoimmune encephalitis autoimmunity B cell receptor biomarker bupropion carriers cellular immunity central nervous system cerebral blood flow chloroquine clinical outcome clinical outcomes clinical phenotype cognitive impairment conformational analysis conjugation cranial nerve-VI palsy craniopharyngioma delivery methods dendritic cells diagnosis diagnostic markers disease-modifying treatments drug delivery nanosystems EAE early-onset ELISA experimental autoimmune encephalomyelitis fampridine fractionated stereotactic radiation treatments free light chains Graphite/SiO2 electrode gut microbiome gut-brain axis HPLC Human Leucocyte Antigens immune modulation immune thrombocytopenic purpura immunogenetics immunoglobulins immunomodulation immunotherapeutics immunotherapy inflammation intracortical facilitation kappa lipids major depression mannan MBP83-99 peptide memory T cells metagenomics microglia MOG35-55 molecular dynamic monoclonal antibodies MS MS drugs multiple sclerosis Multiple Sclerosis multivalency myelin basic protei myelin oligodendrocyte glycoprotein myelin peptides N-glucosylated peptide epitopes nanoparticles nanotechnology neurodegeneration neuroimaging neuropsychological assessment NMR spectroscopy NOE-constraints oligodendrocytes oxidative peptide peptides plasma exchange polymers positron emission tomography probiotics proteolipid protein S-adenosylmethionine sample size short intracortical inhibition sphenoid sinusitis ST285 Streptococcus thermophilus T cell receptor tDCS tetraspanins therapeutics tolerance tolerance induction tolerogenic vaccines trimolecular complex TSPAN32 vaccine vaccines vitamin D3 voltammetry walking disability yoga
Online Access:	Open Access: DOAB: description of the publication Open Access: DOAB, download the publication

Similar Items

Peptide Immunotherapy for Type 1 Diabetes—Clinical Advances
by: Emma L. Smith, et al.
Published: (2018-02-01)

Tolerogenic Immunomodulation by PEGylated Antigenic Peptides
by: Jennifer Pfeil, et al.
Published: (2020-10-01)

Peptide immunotherapy in experimental autoimmune encephalomyelitis
by: Stephen M Anderton
Published: (2015-06-01)

Diagnostic and immunoprophylactic applications of synthetic peptides in veterinary microbiology
by: Saravanan Paramasivam, et al.
Published: (2009-10-01)

Advances in Antigenic Peptide-Based Vaccine and Neutralizing Antibodies against Viruses Causing Hand, Foot, and Mouth Disease
by: Mohd Ishtiaq Anasir, et al.
Published: (2019-03-01)

A Cyclic Altered Peptide Analogue Based on Myelin Basic Protein 87–99 Provides Lasting Prophylactic and Therapeutic Protection Against Acute Experimental Autoimmune Encephalomyelitis
by: Mary Emmanouil, et al.
Published: (2018-01-01)

IMMUNOTHERAPY FOR MELANOMA
by: E. A. Borobova, et al.
Published: (2017-09-01)

Theory and Practice of Immunotherapy Directed against the PRAME Antigen
by: VA Misyurin
Published: (2018-04-01)

Immunogenicity of a Tripartite Cell Penetrating Peptide Containing a MUC1 Variable Number of Tandem Repeat (VNTR) and A T Helper Epitope
by: Nicole Brooks, et al.
Published: (2018-09-01)

Antigen Targets for the Development of Immunotherapies in Leukemia
by: Jens Bauer, et al.
Published: (2019-03-01)

Sensitization of Tumors for Attack by Virus-Specific CD8+ T-Cells Through Antibody-Mediated Delivery of Immunogenic T-Cell Epitopes
by: Julian P. Sefrin, et al.
Published: (2019-08-01)

Comparative Immunogenicity of a Cytotoxic T Cell Epitope Delivered by Penetratin and TAT Cell Penetrating Peptides
by: Nicole Brooks, et al.
Published: (2015-08-01)

Targeting cancers through TCR-peptide/MHC interactions
by: Qinghua He, et al.
Published: (2019-12-01)

Direct modulation of myelin-autoreactive CD4+ and CD8+ T cells in EAE mice by a tolerogenic nanoparticle co-carrying myelin peptide-loaded major histocompatibility complexes, CD47 and multiple regulatory molecules
by: Pei W, et al.
Published: (2018-06-01)

Targeted Expression of Myelin Autoantigen in the Periphery Induces Antigen-Specific T and B Cell Tolerance and Ameliorates Autoimmune Disease
by: Shin-Young Na, et al.
Published: (2021-06-01)

Present and future perspectives on immunotherapy for advanced renal cell carcinoma: Going to the core or beating around the bush?
by: Hidenori Kawashima, et al.
Published: (2015-03-01)

Telomerase-Targeted Cancer Immunotherapy
by: Eishiro Mizukoshi, et al.
Published: (2019-04-01)

An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial
by: Julie Charles, et al.
Published: (2020-01-01)

Antigen-Specific Treatment Modalities in MS: The Past, the Present, and the Future
by: Judith Derdelinckx, et al.
Published: (2021-02-01)

Recognition of a high affinity MHC class I-restricted epitope of myelin oligodendrocyte glycoprotein by CD8+ T cells derived from autoantigen-deficient mice.
by: Melanie D Leech, et al.
Published: (2011-05-01)

Autoimmune Encephalitis and CSF Anti-GluR3 Antibodies in an MS Patient after Alemtuzumab Treatment
by: Maria Chiara Buscarinu, et al.
Published: (2019-10-01)

Conformational epitopes of myelin oligodendrocyte glycoprotein are targets of potentially pathogenic antibody responses in multiple sclerosis
by: Menge Til, et al.
Published: (2011-11-01)

The role of peptide and DNA vaccines in myeloid leukemia immunotherapy
by: Lin Chen, et al.
Published: (2013-02-01)

Peptide Blocking CTLA-4 and B7-1 Interaction
by: Stepan V. Podlesnykh, et al.
Published: (2021-01-01)

Individual MHCI restricted T-cell receptors are characterized by a unique peptide recognition signature
by: Linda eWooldridge
Published: (2013-07-01)

Rational Design and Synthesis of Altered Peptide Ligands based on Human Myelin Oligodendrocyte Glycoprotein 35–55 Epitope: Inhibition of Chronic Experimental Autoimmune Encephalomyelitis in Mice
by: Theodore Tselios, et al.
Published: (2014-11-01)

The Landscape of Tumor-Specific Antigens in Colorectal Cancer
by: Nurul Ainaa Adilah Rus Bakarurraini, et al.
Published: (2020-07-01)

Synthesized OVA<sub>323-339</sub>MAP octamers mitigate OVA-induced airway inflammation by regulating Foxp3 T regulatory cells
by: Su Wen, et al.
Published: (2012-07-01)

Nanostructured SL9-CpG Lipovaccines Elicit Immune Response for the Treatment of Melanoma
by: Li-Min Mu, et al.
Published: (2019-05-01)

CD27 stimulation unveils the efficacy of linked class I/II peptide vaccines in poorly immunogenic tumors by orchestrating a coordinated CD4/CD8 T cell response
by: Katherine A. Riccione, et al.
Published: (2018-12-01)

High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4+ and CD8+ T-Cell Epitopes
by: Fanny Onodi, et al.
Published: (2018-11-01)

Array-based Autoantibody Profiling and Epitope Mapping
by: Zandian, Arash
Published: (2017)

Optimising Cancer Vaccine Design in Sarcoma
by: Alexandra Pender, et al.
Published: (2018-12-01)

An Epitope Platform for Safe and Effective HTLV-1-Immunization: Potential Applications for mRNA and Peptide-Based Vaccines
by: Guglielmo Lucchese, et al.
Published: (2021-07-01)

Anti-Tumor Effects of Peptide Therapeutic and Peptide Vaccine Antibody Co-targeting HER-1 and HER-2 in Esophageal Cancer (EC) and HER-1 and IGF-1R in Triple-Negative Breast Cancer (TNBC)
by: Jay Overholser, et al.
Published: (2015-07-01)

EBV-Associated Cancer and Autoimmunity: Searching for Therapies
by: Giovanni Capone, et al.
Published: (2015-02-01)

Recent Advances in Antigen-Specific Immunotherapies for the Treatment of Multiple Sclerosis
by: Olga Kammona, et al.
Published: (2020-05-01)

A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma
by: Cristian Capasso, et al.
Published: (2017-09-01)

Nanoparticle drug delivery systems: an excellent carrier for tumor peptide vaccines
by: Jiemin Wang, et al.
Published: (2018-01-01)

MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome
by: Sara Mariotto, et al.
Published: (2017-10-01)